Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Oct;34(10):1315–1318. doi: 10.1136/gut.34.10.1315

Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A.

I Biemond 1, J Kreuning 1, J B Jansen 1, C B Lamers 1
PMCID: PMC1374533  PMID: 8244094

Abstract

Hypopepsinogenaemia A is often found in patients with gastric atrophy and gastric surgery. In these conditions serum pepsinogen C provides additional diagnostic information, especially when expressed as pepsinogen A:C ratio. Hyperpepsinogenaemia A has been shown in patients with duodenal ulcer disease, Zollinger-Ellison syndrome, hypertrophic gastropathy, chronic renal failure, and during omeprazole treatment. As patients with hyperpepsinogenaemia A often overlap in symptoms, endoscopical findings, and serum gastrin values, this study has evaluated whether measurement of serum pepsinogen C in subjects with hyperpepsinogenaemia A can help in differentiating clinical conditions. Serum concentrations of pepsinogen A and C were measured in serologically Helicobacter pylori negative blood transfusion donors (127) as reference population, and in patients with Zollinger-Ellison syndrome (24), duodenal ulcer (50), hypertrophic gastropathy (5), and chronic renal failure (50), and also in reflux oesophagitis patients on longterm omeprazole treatment (28). A low pepsinogen A:C ratio was found in all patients with hypertrophic gastropathy. A pepsinogen A:C ratio above the critical value of 4.7 was found in 14 (70.0%) of the Zollinger-Ellison patients, two (9.5%) of the duodenal ulcer patients, 11 (25.6%) of the patients with chronic renal failure, and in one (7.1%) of the patients receiving longterm omeprazole treatment. In fact, all but three hyperpepsinogenaemia A patients with a pepsinogen A:C ratio greater than 4.7 and normal renal function had the Zollinger-Ellison syndrome. In patients with hyperpepsinogenaemia A, a low pepsinogen A:C ratio may point to hypertrophic gastropathy, while a pepsinogen A:C ratio greater than 4.7 is suggestive for the Zollinger-Ellison syndrome.

Full text

PDF
1315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biemond I., Crobach L. F., Jansen J. B., Lamers C. B. Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers. Br J Clin Pharmacol. 1990 Apr;29(4):465–472. doi: 10.1111/j.1365-2125.1990.tb03665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biemond I., Crobach L. F., Jansen J. B., Lamers C. B. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Eur J Clin Pharmacol. 1989;37(4):345–349. doi: 10.1007/BF00558498. [DOI] [PubMed] [Google Scholar]
  3. Biemond I., Jansen J. B., Crobach L. F., Kreuning J., Lamers C. B. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem. 1989 Jan;27(1):19–25. doi: 10.1515/cclm.1989.27.1.19. [DOI] [PubMed] [Google Scholar]
  4. Borch K., Axelsson C. K., Halgreen H., Damkjaer Nielsen M. D., Ledin T., Szesci P. B. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol. 1989 Sep;24(7):870–876. doi: 10.3109/00365528909089228. [DOI] [PubMed] [Google Scholar]
  5. Feldman M., Blair A. J., 3rd, Richardson C. T., Samloff I. M. Effect of proximal gastric vagotomy on serum pepsinogen I and II concentrations and acid secretion in duodenal ulcer patients. Dig Dis Sci. 1988 Jul;33(7):824–827. doi: 10.1007/BF01550970. [DOI] [PubMed] [Google Scholar]
  6. Festen H. P., Thijs J. C., Lamers C. B., Jansen J. M., Pals G., Frants R. R., Défize J., Meuwissen S. G. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology. 1984 Nov;87(5):1030–1034. [PubMed] [Google Scholar]
  7. Ichinose M., Miki K., Furihata C., Kageyama T., Hayashi R., Niwa H., Oka H., Matsushima T., Takahashi K. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta. 1982 Dec 9;126(2):183–191. doi: 10.1016/0009-8981(82)90034-1. [DOI] [PubMed] [Google Scholar]
  8. Lam S. K., Hui W. K., Ho J., Wong K. P., Rotter J. I., Samloff I. M. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology. 1983 Apr;84(4):834–839. [PubMed] [Google Scholar]
  9. Lamers C. B., Rotter J. I., Jansen J. B., Samloff I. M. Serum pepsinogen I in familial multiple endocrine neoplasia type I. Dig Dis Sci. 1988 Oct;33(10):1274–1276. doi: 10.1007/BF01536679. [DOI] [PubMed] [Google Scholar]
  10. Paimela H., Härkönen M., Karonen S. L., Tallgren L. G., Ahonen J. The effect of renal transplantation on gastric acid secretion and on the serum levels of gastrin and group I pepsinogens. Ann Clin Res. 1985;17(3):105–109. [PubMed] [Google Scholar]
  11. Peetsalu A., Tamm A., Härkönen M., Varis K., Sipponen P., Karonen S. L., Väli T., Villako K. The effect of vagotomy and antrectomy on serum pepsinogens I and II. Scand J Gastroenterol. 1990 May;25(5):455–461. doi: 10.3109/00365529009095515. [DOI] [PubMed] [Google Scholar]
  12. Peña A. S., Endtz H. P., Offerhaus G. J., Hoogenboom-Verdegaal A., van Duijn W., de Vargas N., den Hartog G., Kreuning J., van der Reyden J., Mouton R. P. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion. 1989;44(3):131–141. doi: 10.1159/000199902. [DOI] [PubMed] [Google Scholar]
  13. Samloff I. M., Liebman W. M., Panitch N. M. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology. 1975 Jul;69(1):83–90. [PubMed] [Google Scholar]
  14. Samloff I. M. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology. 1982 Jan;82(1):26–33. [PubMed] [Google Scholar]
  15. Samloff I. M., Varis K., Ihamaki T., Siurala M., Rotter J. I. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982 Jul;83(1 Pt 2):204–209. [PubMed] [Google Scholar]
  16. Sipponen P., Samloff I. M., Saukkonen M., Varis K. Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy. Gut. 1985 Nov;26(11):1179–1182. doi: 10.1136/gut.26.11.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  18. Waldum H. L., Jorde R., Gunnes P. Renal excretion of and the effect of posture on serum group I pepsinogens. Scand J Gastroenterol. 1982 Mar;17(2):253–255. doi: 10.3109/00365528209182048. [DOI] [PubMed] [Google Scholar]
  19. Westerveld B. D., Pals G., Lamers C. B., Defize J., Pronk J. C., Frants R. R., Ooms E. C., Kreuning J., Kostense P. J., Eriksson A. W. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer. 1987 Mar 1;59(5):952–958. doi: 10.1002/1097-0142(19870301)59:5<952::aid-cncr2820590517>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES